Advertisement
UK markets close in 6 hours
  • FTSE 100

    8,107.46
    +28.60 (+0.35%)
     
  • FTSE 250

    19,828.20
    +226.22 (+1.15%)
     
  • AIM

    755.98
    +2.86 (+0.38%)
     
  • GBP/EUR

    1.1654
    -0.0003 (-0.02%)
     
  • GBP/USD

    1.2513
    +0.0003 (+0.02%)
     
  • Bitcoin GBP

    51,548.03
    +358.75 (+0.70%)
     
  • CMC Crypto 200

    1,390.62
    -5.92 (-0.42%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    83.73
    +0.16 (+0.19%)
     
  • GOLD FUTURES

    2,362.90
    +20.40 (+0.87%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,041.63
    +124.35 (+0.69%)
     
  • CAC 40

    8,029.93
    +13.28 (+0.17%)
     

Why Earnings Season Could Be Great for Johnson & Johnson (JNJ)

Investors are always looking for stocks that are poised to beat at earnings season and Johnson & Johnson JNJ may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

That is because Johnson & Johnsonis seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for JNJ in this report.

In fact, the Most Accurate Estimate for the current quarter is currently at $1.88 per share for JNJ, compared to a broader Zacks Consensus Estimate of $1.87 per share. This suggests that analysts have very recently bumped up their estimates for JNJ, giving the stock a Zacks Earnings ESP of +0.77% heading into earnings season.

Johnson & Johnson Price and EPS Surprise

Johnson & Johnson Price and EPS Surprise
Johnson & Johnson Price and EPS Surprise

Johnson & Johnson price-eps-surprise | Johnson & Johnson Quote

ADVERTISEMENT

Why is this Important?

A positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10-year backtest shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns (see more Top Earnings ESP stocks here).

Given that JNJ has a Zacks Rank #2 (Buy) and an ESP in positive territory, investors might want to consider this stock ahead of earnings. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Clearly, recent earnings estimate revisions suggest that good things are ahead for Johnson & Johnson, and that a beat might be in the cards for the upcoming report.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Johnson & Johnson (JNJ) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.